Fulgent Genetics, Inc. (FLGT)
24.12
-0.66
(-2.66%)
USD |
NASDAQ |
Nov 20, 16:00
24.11
-0.01
(-0.04%)
After-Hours: 20:00
Fulgent Genetics Cash from Operations (Annual) : -101.64M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -101.64M |
| December 31, 2024 | 21.06M |
| December 31, 2023 | 27.00M |
| December 31, 2022 | 253.52M |
| December 31, 2021 | 538.59M |
| December 31, 2020 | 140.63M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.517M |
| December 31, 2018 | -0.675M |
| December 31, 2017 | 1.331M |
| December 31, 2016 | 4.405M |
| December 31, 2015 | -0.969M |
| December 31, 2014 | -4.397M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Quest Diagnostics, Inc. | 1.886B |
| Labcorp Holdings, Inc. | 1.640B |
| OPKO Health, Inc. | -178.54M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 5.23M |